BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30967995)

  • 1.
    Zhou Q; Zhang F; He Z; Zuo MZ
    Front Oncol; 2019; 9():161. PubMed ID: 30967995
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
    Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
    Front Oncol; 2020; 10():606735. PubMed ID: 33604289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer.
    Zhou Q; Hou CN; Yang HJ; He Z; Zuo MZ
    Cancer Manag Res; 2018; 10():6937-6948. PubMed ID: 30588099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
    Li Y; Huang J; Yang D; Xiang S; Sun J; Li H; Ren G
    Oncol Lett; 2018 Jun; 15(6):9216-9230. PubMed ID: 29844824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of E2F Family Members in Human Gastric Cancer.
    Li S; Yang X; Li W; Chen Z
    Front Oncol; 2021; 11():625257. PubMed ID: 34532281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.
    Liu X; Hu C
    Mol Ther Methods Clin Dev; 2020 Sep; 18():824-838. PubMed ID: 32953933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis.
    Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Zhang F; Shao S; Chen X; Chen X
    Int J Gen Med; 2022; 15():4849-4870. PubMed ID: 35585998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.
    Sun CC; Zhou Q; Hu W; Li SJ; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; Tang QZ; Li DJ
    Aging (Albany NY); 2018 May; 10(5):973-987. PubMed ID: 29754146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic study on expression and prognosis of E2Fs in human colorectal cancer.
    Ma Y; Wang S; Bao J; Wang C
    Int J Clin Oncol; 2022 Feb; 27(2):362-372. PubMed ID: 34661779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions and prognostic values of the
    Liu ZL; Bi XW; Liu PP; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
    Cancer Manag Res; 2018; 10():3521-3532. PubMed ID: 30271201
    [No Abstract]   [Full Text] [Related]  

  • 11. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
    Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
    Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer.
    Fan Y; Li T; Xu L; Kuang T
    Comput Math Methods Med; 2020; 2020():6138039. PubMed ID: 33062039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinoma.
    Yang C; Zhang ZC; Liu TB; Xu Y; Xia BR; Lou G
    Cancer Cell Int; 2020; 20():500. PubMed ID: 33061852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
    Hu D; Meng N; Lou X; Li Z; Teng Y; Tu B; Zou Y; Wang F
    Int J Gen Med; 2021; 14():3593-3609. PubMed ID: 34295182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
    Zhang C; Cui Y; Wang G; Zhao W; Zhao H; Huang X; Zhang M; Li W
    J Healthc Eng; 2021; 2021():5790416. PubMed ID: 34531966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis.
    Liang B; Zhao J; Wang X
    Genes Cancer; 2017 May; 8(5-6):600-607. PubMed ID: 28740578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer.
    Liao P; Han S; Qu H
    Biomed Res Int; 2020; 2020():6281635. PubMed ID: 33381564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional E2F1/2/3/6 as potential prognostic biomarkers in cutaneous melanoma.
    Li J; Shu XL; Shao Q; Luo Q; Diao QC; Zhang X; Sui JD; Guo J; Tao D; Zhou X; Wang Y; Wang C
    Am J Transl Res; 2021; 13(1):420-433. PubMed ID: 33527034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the Expression of
    Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
    Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.